Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2014

01.12.2014 | Laboratory Investigation

Computer-extracted MR imaging features are associated with survival in glioblastoma patients

verfasst von: Maciej A. Mazurowski, Jing Zhang, Katherine B. Peters, Hasan Hobbs

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Automatic survival prognosis in glioblastoma (GBM) could result in improved treatment planning for the patient. The purpose of this research is to investigate the association of survival in GBM patients with tumor features in pre-operative magnetic resonance (MR) images assessed using a fully automatic computer algorithm. MR imaging data for 68 patients from two US institutions were used in this study. The images were obtained from the Cancer Imaging Archive. A fully automatic computer vision algorithm was applied to segment the images and extract eight imaging features from the MRI studies. The features included tumor side, proportion of enhancing tumor, proportion of necrosis, T1/FLAIR ratio, major axis length, minor axis length, tumor volume, and thickness of enhancing margin. We constructed a multivariate Cox proportional hazards regression model and used a likelihood ratio test to establish whether the imaging features are prognostic of survival. We also evaluated the individual prognostic value of each feature through multivariate analysis using the multivariate Cox model and univariate analysis using univariate Cox models for each feature. We found that the automatically extracted imaging features were predictive of survival (p = 0.031). Multivariate analysis of individual features showed that two individual features were predictive of survival: proportion of enhancing tumor (p = 0.013), and major axis length (p = 0.026). Univariate analysis indicated the same two features as significant (p = 0.021, and p = 0.017 respectively). We conclude that computer-extracted MR imaging features can be used for survival prognosis in GBM patients.
Literatur
1.
Zurück zum Zitat Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology 14(suppl 5):v1–v49PubMedCentralPubMedCrossRef Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology 14(suppl 5):v1–v49PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466PubMedCrossRef Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466PubMedCrossRef
3.
Zurück zum Zitat Stupp R, Mason WP, Van Den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRef Stupp R, Mason WP, Van Den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRef
4.
Zurück zum Zitat Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198PubMedCrossRef Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198PubMedCrossRef
5.
Zurück zum Zitat Park JK, Hodges T, Arko L et al (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28(24):3838–3843PubMedCentralPubMedCrossRef Park JK, Hodges T, Arko L et al (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28(24):3838–3843PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat McDonald KL, Aw G, Kleihues P (2012) Role of biomarkers in the clinical management of glioblastomas: what are the barriers and how can we overcome them?, Front Neurol, 3 McDonald KL, Aw G, Kleihues P (2012) Role of biomarkers in the clinical management of glioblastomas: what are the barriers and how can we overcome them?, Front Neurol, 3
7.
Zurück zum Zitat Verhaak RG, Hoadley KA, Purdom E et al (2010) An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell 17(1):98PubMedCentralPubMedCrossRef Verhaak RG, Hoadley KA, Purdom E et al (2010) An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell 17(1):98PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Gorlia T, van den Bent MJ, Hegi ME et al (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3. Lancet Oncol 9(1):29–38PubMedCrossRef Gorlia T, van den Bent MJ, Hegi ME et al (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3. Lancet Oncol 9(1):29–38PubMedCrossRef
11.
Zurück zum Zitat Rivera AL, Pelloski CE, Gilbert MR et al (2010) MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-oncology 12(2):116–121PubMedCentralPubMedCrossRef Rivera AL, Pelloski CE, Gilbert MR et al (2010) MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-oncology 12(2):116–121PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Minniti G, Salvati M, Arcella A et al (2011) Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurooncol 102(2):311–316PubMedCrossRef Minniti G, Salvati M, Arcella A et al (2011) Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurooncol 102(2):311–316PubMedCrossRef
13.
Zurück zum Zitat Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF (2005) MR imaging correlates of survival in patients with high-grade gliomas. Am j neuroradiol 26(10):2466–2474PubMed Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF (2005) MR imaging correlates of survival in patients with high-grade gliomas. Am j neuroradiol 26(10):2466–2474PubMed
14.
Zurück zum Zitat Zinn PO, Sathyan P, Mahajan B et al (2012) A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature. PLoS One 7(8):e41522PubMedCentralPubMedCrossRef Zinn PO, Sathyan P, Mahajan B et al (2012) A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature. PLoS One 7(8):e41522PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Gutman DA, Cooper LA, Hwang SN et al (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267(2):560–569PubMedCentralPubMedCrossRef Gutman DA, Cooper LA, Hwang SN et al (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267(2):560–569PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Mazurowski MA, Desjardins A, Malof JM (2013) Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro-oncology 15(10):1389–1394PubMedCentralPubMedCrossRef Mazurowski MA, Desjardins A, Malof JM (2013) Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro-oncology 15(10):1389–1394PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Zacharaki E, Morita N, Bhatt P, O’Rourke D, Melhem E, Davatzikos C (2012) Survival analysis of patients with high-grade gliomas based on data mining of imaging variables. Am J Neuroradiol 33(6):1065–1071PubMedCrossRef Zacharaki E, Morita N, Bhatt P, O’Rourke D, Melhem E, Davatzikos C (2012) Survival analysis of patients with high-grade gliomas based on data mining of imaging variables. Am J Neuroradiol 33(6):1065–1071PubMedCrossRef
18.
Zurück zum Zitat Zhou M, Hall LO, Goldgof DB, Gillies RJ, Gatenby RA (2013) Survival time prediction of patients with glioblastoma multiforme tumors using spatial distance measurement. SPIE Med Imaging: Int Soc Opt Photonics, p. 86702O-O-7 Zhou M, Hall LO, Goldgof DB, Gillies RJ, Gatenby RA (2013) Survival time prediction of patients with glioblastoma multiforme tumors using spatial distance measurement. SPIE Med Imaging: Int Soc Opt Photonics, p. 86702O-O-7
19.
Zurück zum Zitat Popuri K, Cobzas D, Murtha A, Jägersand M (2012) 3D variational brain tumor segmentation using Dirichlet priors on a clustered feature set. Int J Comput Assist Radiol Surg 7(4):493–506PubMedCrossRef Popuri K, Cobzas D, Murtha A, Jägersand M (2012) 3D variational brain tumor segmentation using Dirichlet priors on a clustered feature set. Int J Comput Assist Radiol Surg 7(4):493–506PubMedCrossRef
20.
Zurück zum Zitat Zhu Y, Young GS, Xue Z et al (2012) Semi-automatic segmentation software for quantitative clinical brain glioblastoma evaluation. Acad Radiol 19(8):977–985PubMedCentralPubMedCrossRef Zhu Y, Young GS, Xue Z et al (2012) Semi-automatic segmentation software for quantitative clinical brain glioblastoma evaluation. Acad Radiol 19(8):977–985PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Zikic D, Glocker B, Konukoglu E, et al. (2012) Decision forests for tissue-specific segmentation of high-grade gliomas in multi-channel MR. Medical Image Computing and Computer-Assisted Intervention–MICCAI 2012, Berlin: Springer, pp 369–376 Zikic D, Glocker B, Konukoglu E, et al. (2012) Decision forests for tissue-specific segmentation of high-grade gliomas in multi-channel MR. Medical Image Computing and Computer-Assisted Intervention–MICCAI 2012, Berlin: Springer, pp 369–376
22.
Zurück zum Zitat Zhang J, Barboriak DP, Hobbs H, Mazurowski MA (2013) A fully automatic extraction of magnetic resonance image features in Glioblastoma patients. Med Phys 41(4):042301CrossRef Zhang J, Barboriak DP, Hobbs H, Mazurowski MA (2013) A fully automatic extraction of magnetic resonance image features in Glioblastoma patients. Med Phys 41(4):042301CrossRef
Metadaten
Titel
Computer-extracted MR imaging features are associated with survival in glioblastoma patients
verfasst von
Maciej A. Mazurowski
Jing Zhang
Katherine B. Peters
Hasan Hobbs
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2014
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-014-1580-5

Weitere Artikel der Ausgabe 3/2014

Journal of Neuro-Oncology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.